Antibodies to Escherichia coli in chronic liver diseases.
Open Access
- 1 November 1975
- Vol. 16 (11), 871-875
- https://doi.org/10.1136/gut.16.11.871
Abstract
Patients with chronic active hepatitis or alcoholic cirrhosis have serum antibodies to many more serotypes of Escherichia coli than do patients with primary biliary cirrhosis or cryptogenic cirrhosis, or normal controls. They also have antibodies against more serotypes than cirrhotic patients with a portacaval shunt. These observations suggest that factors other than shunting of blood away from the liver are responsible for the increased range of antibodies. These factors are discussed. There was no correlation between the number of serotypes to which antibodies were present and the serum immunoglobulin concentration. In three patients, each with chronic active hepatitis, the antibodies were predominantly of the IgM class, while the elevation of globulin in general was mainly due to increased IgG and IgA levels. Antibodies to Escherichia coli, therefore, probably contribute only a small part of the increased globulin levels found in patients with chronic liver disease.Keywords
This publication has 20 references indexed in Scilit:
- Increased serum immunoglobulin levels following portacaval shunt in the normal ratGut, 1974
- RELATION OF RENAL IMPAIRMENT AND HAEMORRHAGIC DIATHESIS TO ENDOTOXAEMIA IN FULMINANT HEPATIC FAILUREThe Lancet, 1974
- Immunogenicity, Tolerogenicity, and Mitogenicity of LipopolysaccharidesThe Journal of Infectious Diseases, 1973
- HYPERGLOBULINÆMIA IN LIVER DISEASEThe Lancet, 1973
- ROLE OF THE LIVER IN CONTROLLING THE IMMUNOGENICITY OF COMMENSAL BACTERIA IN THE GUTThe Lancet, 1973
- ANTIBODIES TO INTESTINAL MICROBES IN SERUM OF PATIENTS WITH CIRRHOSIS OF THE LIVERThe Lancet, 1972
- UNRESPONSIVENESS TO SELF ANTIGENSThe Lancet, 1971
- ANTI-SALMONELLA AGGLUTININS IN CHRONIC ACTIVE LIVER DISEASEThe Lancet, 1971
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965
- SERUM-ANTIBODY LEVELS AS AN INDICATION OF CLINICALLY INAPPARENT PYELONEPHRITISThe Lancet, 1964